Your browser doesn't support javascript.
loading
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss.
Murali, Bhavna; Ren, Qihao; Luo, Xianmin; Faget, Douglas V; Wang, Chun; Johnson, Radia Marie; Gruosso, Tina; Flanagan, Kevin C; Fu, Yujie; Leahy, Kathleen; Alspach, Elise; Su, Xinming; Ross, Michael H; Burnette, Barry; Weilbaecher, Katherine N; Park, Morag; Mbalaviele, Gabriel; Monahan, Joseph B; Stewart, Sheila A.
Afiliação
  • Murali B; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Ren Q; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Luo X; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Faget DV; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Wang C; Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.
  • Johnson RM; Goodman Cancer Center, Department of Oncology, Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
  • Gruosso T; Goodman Cancer Center, Department of Oncology, Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
  • Flanagan KC; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Fu Y; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Leahy K; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Alspach E; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Su X; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Ross MH; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Burnette B; Aclaris Therapeutics, Inc., Saint Louis, Missouri.
  • Weilbaecher KN; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Park M; Goodman Cancer Center, Department of Oncology, Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
  • Mbalaviele G; Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri.
  • Monahan JB; Aclaris Therapeutics, Inc., Saint Louis, Missouri.
  • Stewart SA; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri. sheila.stewart@wustl.edu.
Cancer Res ; 78(19): 5618-5630, 2018 10 01.
Article em En | MEDLINE | ID: mdl-30093561
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osso e Ossos / Neoplasias da Mama / Proteínas Serina-Treonina Quinases / Proteínas Quinases p38 Ativadas por Mitógeno / Peptídeos e Proteínas de Sinalização Intracelular / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osso e Ossos / Neoplasias da Mama / Proteínas Serina-Treonina Quinases / Proteínas Quinases p38 Ativadas por Mitógeno / Peptídeos e Proteínas de Sinalização Intracelular / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article